P-055: TRIAL IN PROGRESS: A PHASE 2, OPEN-LABEL STUDY EVALUATING THE SAFETY AND EFFICACY OF THE ERYTHROCYTE PYRUVATE KINASE ACTIVATOR ETAVOPIVAT IN PATIENTS WITH THALASSEMIA OR SICKLE CELL DISEASE.

Autor: T., COATES, A., LAL, R., BROWN, T., KALFA, J., KWIATKOWSKI, J., BREVARD, C., TRENOR, K., WOOD, S., SHETH
Zdroj: HemaSphere; 2022 Supplement 4, Vol. 6, p43-44, 2p
Databáze: Complementary Index
Externí odkaz: